Ayala Pharmaceuticals, Inc. Annual Nonoperating Income (Expense) in USD from 2022 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Ayala Pharmaceuticals, Inc. annual/quarterly Nonoperating Income (Expense) history and growth rate from 2022 to 2023.
  • Ayala Pharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2023 was -$143K, a 14400% decline year-over-year.
  • Ayala Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2023 was -$15.7M, a 21341% decline from 2022.
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.